"Disclosure: This post was sponsored by Galderma Laboratories L.P. through their partnership with POPSUGAR. While I was compensated by POPSUGAR to write a post about Mirvaso, all opinions are my own."
it seems like a lifetime ago but i once worked as an esthetician in a Plastic Surgeon's office. one of the many skin complaints i helped treat was facial redness. facial redness is such a tricky thing because if you use the wrong products, it will only make the redness worse, however the right products can sometimes not completely help either. facial redness is caused by broken capillaries near the surface of the skin which is what causes that red hue. so what is a person going to do with facial redness? makeup, a lot of makeup.
Galderma has launched a leading skincare product called Mirvaso®. Mirvaso® (brimonidine) topical gel, 0.33%* is topical product that is to be applied to the face to help those suffering from the persistent facial redness of rosacea. you apply a pea sized amount to each of the five areas of your face (forehead, nose, chin and each cheek) once a day. this gel helps reduce Rosacea redness for up to twelve hours. for those who suffer from persistent redness, this is quite a relief!
now that Galderma is offering you an alternative to treating persistent red skin with more than just makeup, Mirvaso® is giving you the chance to Break Up With Your Makeup! this is an opportunity to win a star studded walk down the red carpet at the Emmys. simply head to the Mirvaso® website here and enter your email address for a chance to win.
“Important Safety Information
Indication: Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.”